These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29992848)

  • 1. The quest for the in medio stat virtus price in the oncology sector.
    Petrou P
    J Med Econ; 2018 Oct; 21(10):1023-1025. PubMed ID: 29992848
    [No Abstract]   [Full Text] [Related]  

  • 2. Sticker shock.
    Couzin-Frankel J
    Science; 2018 Mar; 359(6382):1348-1349. PubMed ID: 29567704
    [No Abstract]   [Full Text] [Related]  

  • 3. Baying for a flexible drug price.
    Lancet; 2009 Nov; 374(9704):1794. PubMed ID: 19944844
    [No Abstract]   [Full Text] [Related]  

  • 4. Toward affordable cancer drugs: Do we need firmer price negotiation, me-too drugs, or a biosimilar silver bullet?
    Fundytus A; Sullivan R; Booth CM
    Semin Oncol; 2020 Dec; 47(6):353-354. PubMed ID: 33153752
    [No Abstract]   [Full Text] [Related]  

  • 5. The cancer pill not taken costs insurers in long run.
    Diamond F
    Manag Care; 2012 Dec; 21(12):20-3, 28. PubMed ID: 23301347
    [No Abstract]   [Full Text] [Related]  

  • 6. Why clinical oncologists should talk about the price of cancer drugs.
    Berlinger N
    Virtual Mentor; 2013 Aug; 15(8):677-80. PubMed ID: 23937783
    [No Abstract]   [Full Text] [Related]  

  • 7. Dying to survive and cancer care in China.
    Lucas C
    Lancet Oncol; 2019 Jan; 20(1):30. PubMed ID: 30614464
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug sales bring huge profits, and scrutiny, to cancer doctors: insurers and experts see high costs and conflicts.
    Abelson R
    N Y Times Web; 2003 Jan; ():A1, 18. PubMed ID: 12647757
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacoeconomic analyses make way into oncology.
    Amber D
    J Natl Cancer Inst; 2000 Aug; 92(15):1204-5. PubMed ID: 10922402
    [No Abstract]   [Full Text] [Related]  

  • 10. [Economic effects of "molecular" medicine].
    Riemann JF
    Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1740. PubMed ID: 17713881
    [No Abstract]   [Full Text] [Related]  

  • 11. Health policy: Putting a price on cancer.
    Sullivan R; Aggarwal A
    Nat Rev Clin Oncol; 2016 Mar; 13(3):137-8. PubMed ID: 26856742
    [No Abstract]   [Full Text] [Related]  

  • 12. Carbon-Ion Therapy: One More Step in the Endless Quest for the Ideal Dose Distribution.
    Schulz RJ; Kagan AR
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):561. PubMed ID: 27084666
    [No Abstract]   [Full Text] [Related]  

  • 13. A pharmacoeconomic modeling approach to estimate a value-based price for new oncology drugs in Europe.
    Dranitsaris G; Ortega A; Lubbe MS; Truter I
    J Oncol Pharm Pract; 2012 Mar; 18(1):57-67. PubMed ID: 21382915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on Cost and Value in Cancer Care.
    Saltz LB
    JAMA Oncol; 2016 Jan; 2(1):19-21. PubMed ID: 26501848
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple Dimensions of Value: Evaluative Frameworks for New Cancer Therapies.
    Cheung MC; Sabharwal M; Chambers A; Han D; Sabarre KA; Chan K
    J Clin Oncol; 2016 Apr; 34(12):1428-9. PubMed ID: 26884567
    [No Abstract]   [Full Text] [Related]  

  • 16. Paying a high price for cancer drugs.
    Lancet; 2015 Aug; 386(9992):404. PubMed ID: 26251376
    [No Abstract]   [Full Text] [Related]  

  • 17. Rewarding value creation to promote innovation in oncology: The importance of considering the global product life cycle.
    Garrison LP
    Oncologist; 2010; 15 Suppl 1():49-57. PubMed ID: 20237218
    [No Abstract]   [Full Text] [Related]  

  • 18. NICE, the NHS, and Cancer Drugs.
    Dillon A; Landells LJ
    JAMA; 2018 Feb; 319(8):767-768. PubMed ID: 29387883
    [No Abstract]   [Full Text] [Related]  

  • 19. Oncology drug pricing structure is broken.
    Hutchinson L
    Nat Rev Clin Oncol; 2015 Sep; 12(9):499. PubMed ID: 26309071
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methodology of pharmacoeconomic studies in oncology].
    Ballatori E
    Recenti Prog Med; 2008 Jan; 99(1):42-7. PubMed ID: 18389873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.